Johns Hopkins Drug Discovery - Barbara Slusher
page-template,page-template-full_width,page-template-full_width-php,page,page-id-689,page-child,parent-pageid-41,ajax_fade,page_not_loaded,,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-4.12.1,vc_responsive

Barbara Slusher

Barbara Slusher, Ph.D., MAS

Director, Johns Hopkins Drug Discovery Program

Barbara Slusher

Rangos 278


Barbara Slusher, Ph.D., MAS, is Professor of Neurology, Medicine, Psychiatry, and Neuroscience at Johns Hopkins School of Medicine and the Director of the Johns Hopkins Drug Discovery program. She received her undergraduate degree from Dickinson College where she graduated valedictorian, majoring in Chemistry. She received her Ph.D. in Pharmacology and Molecular Sciences from John Hopkins School of Medicine while simultaneously earning her Master’s degree in Administrative Science from the Johns Hopkins Carey School of Business (formerly the School of Continuing Studies). Before joining Johns Hopkins in 2010, Dr. Slusher spent 18 years in the pharmaceutical industry, including several years at the level of Senior Vice President of Research and Translational Development.


She has extensive experience in drug discovery through early clinical development and was involved in the successful development, launch and/or post marketing support of several branded medicines including Seroquel™, Aloxi™, Dacogen™, and Lucida™. Dr. Slusher has published over 150 scientific articles and is the inventor on over 70 patents and applications. She has been an invited speaker at numerous national and international scientific meetings and has served on the board or as a scientific consultant of multiple biotechnology and Pharma companies. She is a co-founder of Cerecor, a CNS-focused biopharma company in Baltimore ( She also founded and is leading the first-ever International Consortium of Academic Drug Discovery ( with over 100 university-led translational centers and 1000 members in an effort to coordinate and enhance academic drug discovery efforts.